GSK declares positive results from phase III trial for Blenrep in relapsed/ refractory multiple myeloma Ruchika Sharma28 Nov 2023 12:30 PM ISTLondon: GSK plc has announced positive headline results from a planned interim efficacy analysis of the DREAMM-7 head-to-head phase III trial...
GSK to start phase 3 trials of low-carbon Ventolin inhaler in 2024 Ruchika Sharma23 Nov 2023 3:26 PM ISTLondon: GSK plc has announced it will start Phase III trials of a low carbon version of its metered dose inhaler (MDI), Ventolin (salbutamol), using a...
GSK gets positive EMA Committee opinion recommending Momelotinib for myelofibrosis patients with anaemia Ruchika Sharma15 Nov 2023 2:30 PM ISTLondon: GSK plc has announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive...
GSK's India arm reports 12.5 percent Q2 profit at Rs 218 crore Ruchika Sharma13 Nov 2023 12:45 PM ISTBengaluru: GlaxoSmithKline Pharmaceuticals reported a 12.5% rise in quarterly profit as the Indian unit of UK's GSK plc saw strong demand for its...
GSK enters agreement to obtain exclusive license for hepatitis B therapy to expand bepirovirsen development Ruchika Sharma1 Nov 2023 11:30 AM ISTGSK will be responsible for upfront and potential milestone-based payments to both Janssen and Arrowhead totalling approximately USD 1 billion.
Phase III trial of Jemperli plus chemotherapy meets endpoint of overall survival in patients with primary advanced or recurrent endometrial cancer: GSK Ruchika Sharma31 Oct 2023 11:35 AM ISTLondon: GSK plc has announced positive headline results from a planned analysis of Part 1 of the RUBY/ENGOT-EN6/GOG3031/NSGO phase III trial...
Sanofi considers listing consumer unit late next year Ruchika Sharma30 Oct 2023 2:30 PM ISTNew Delhi: Sanofi has mapped out a separate listing of its consumer healthcare business from the fourth quarter of next year, the French drugmaker...
HIV-1 injectable treatment: GSK's ViiV Healthcare gets Chinese nod for Vocabria used in combination with Rekambys Ruchika Sharma26 Oct 2023 4:21 PM ISTLondon: GSK plc has announced that ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as...
GSK, Hansoh Pharma ink pact for HS-20089 Ruchika Sharma24 Oct 2023 3:30 PM ISTUnder the terms of this agreement, GSK will pay an USD 85 million upfront payment.
GSK gets positive EMA Committee opinion recommending approval of Jemperli plus chemotherapy for endometrial cancer Ruchika Sharma19 Oct 2023 2:41 PM ISTUK: GSK plc has announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive...
Another California lawsuit on heartburn drug Zantac settled by GSK Ruchika Sharma11 Oct 2023 4:30 PM ISTThe FDA in 2020 pulled all brand name Zantac and generic versions of the drug off the market, triggering a wave of lawsuits.
GSK, Zhifei to co-promote shingles vaccine Shingrix in China Ruchika Sharma10 Oct 2023 12:30 PM ISTSubject to the terms of the agreement, Zhifei will purchase agreed volumes of Shingrix with a value to GSK of £2.5 billion in total over the initial...
